Go Back
Kli Capital
Kli Capital, a New York-based venture fund founded in 2014, focuses on Seed, Series A, and Series B investments across various sectors including AgTech, ClimateTech, FinTech, Healthcare, InsurTech, Mobile, PropTech, SaaS, and TMT. With Elias Davis as a partner, the fund has invested in 53 companies like SPR Therapeutics and Reach Labs, with 4 successful exits. Kli Capital aims to support entrepreneurs developing enterprise technologies and consumer brands. For more information, visit their website at www.klicapital.vc or reach out to Elias Davis at elias@klicapital.vc.
About
About
About
Bio
Kli Capital focuses on investing in entrepreneurs who are building foundational enterprise technologies and ubiquitous consumer brands.
Location
New York
Stage
Seed, Series A, Series B
Partner name
Elias Davis
Bio
Kli Capital focuses on investing in entrepreneurs who are building foundational enterprise technologies and ubiquitous consumer brands.
Location
New York
Stage
Seed, Series A, Series B
Partner name
Elias Davis
Fund
Fund
Fund
Fund Focus
AgTech (FarmTech), ClimateTech & CleanTech, FinTech, Healthcare, InsurTech, Mobile, PropTech, SaaS, Telecommunications (TMT)
Number of investments
53
Number of exits
4
Fund Type
Venture Fund
Portfolio Companies
SPR Therapeutics, Reach Labs
Kli Capital
Kli Capital, a New York-based venture fund founded in 2014, focuses on Seed, Series A, and Series B investments across various sectors including AgTech, ClimateTech, FinTech, Healthcare, InsurTech, Mobile, PropTech, SaaS, and TMT. With Elias Davis as a partner, the fund has invested in 53 companies like SPR Therapeutics and Reach Labs, with 4 successful exits. Kli Capital aims to support entrepreneurs developing enterprise technologies and consumer brands. For more information, visit their website at www.klicapital.vc or reach out to Elias Davis at elias@klicapital.vc.
About
Bio
Kli Capital focuses on investing in entrepreneurs who are building foundational enterprise technologies and ubiquitous consumer brands.
Location
New York
Stage
Seed, Series A, Series B
Partner name
Elias Davis
Fund
Fund Focus
AgTech (FarmTech), ClimateTech & CleanTech, FinTech, Healthcare, InsurTech, Mobile, PropTech, SaaS, Telecommunications (TMT)
Number of investments
53
Number of exits
4
Fund Type
Venture Fund
Portfolio Companies
SPR Therapeutics, Reach Labs